Your browser doesn't support javascript.
loading
Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
Haselmann, Verena; Kurz, Alexandra; Bertsch, Uwe; Hübner, Sebastian; Olempska-Müller, Monika; Fritsch, Jürgen; Häsler, Robert; Pickl, Andreas; Fritsche, Hendrik; Annewanter, Franka; Engler, Christine; Fleig, Barbara; Bernt, Alexander; Röder, Christian; Schmidt, Hendrik; Gelhaus, Christoph; Hauser, Charlotte; Egberts, Jan-Hendrik; Heneweer, Carola; Rohde, Anna Maria; Böger, Christine; Knippschild, Uwe; Röcken, Christoph; Adam, Dieter; Walczak, Henning; Schütze, Stefan; Janssen, Ottmar; Wulczyn, F Gregory; Wajant, Harald; Kalthoff, Holger; Trauzold, Anna.
Afiliación
  • Haselmann V; Division of Molecular Oncology, Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
  • Kurz A; Division of Molecular Oncology, Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
  • Bertsch U; Institute of Immunology, University of Kiel, Kiel, Germany.
  • Hübner S; Division of Molecular Oncology, Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
  • Olempska-Müller M; Division of Molecular Oncology, Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
  • Fritsch J; Institute of Immunology, University of Kiel, Kiel, Germany.
  • Häsler R; Institute of Clinical Molecular Biology, University of Kiel, Kiel, Germany.
  • Pickl A; Division of Molecular Oncology, Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
  • Fritsche H; Division of Molecular Oncology, Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
  • Annewanter F; Division of Molecular Oncology, Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
  • Engler C; Division of Molecular Oncology, Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
  • Fleig B; Division of Molecular Oncology, Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
  • Bernt A; Division of Molecular Oncology, Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
  • Röder C; Division of Molecular Oncology, Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
  • Schmidt H; Institute of Immunology, University of Kiel, Kiel, Germany.
  • Gelhaus C; Zoological Institute, University of Kiel, Kiel, Germany.
  • Hauser C; Division of Molecular Oncology, Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany; Clinic for General Surgery, Visceral, Thoracic, Transplantation and Pediatric Surgery, University of Kiel, Kiel, Germany.
  • Egberts JH; Clinic for General Surgery, Visceral, Thoracic, Transplantation and Pediatric Surgery, University of Kiel, Kiel, Germany.
  • Heneweer C; Clinic for Diagnostic Radiology, University of Kiel, Kiel, Germany.
  • Rohde AM; Center for Anatomy, Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Böger C; Institute of Pathology, University of Kiel, Kiel, Germany.
  • Knippschild U; Department of General, Visceral and Transplantation Surgery, Centre of Surgery, University of Ulm, Ulm, Germany.
  • Röcken C; Institute of Pathology, University of Kiel, Kiel, Germany.
  • Adam D; Institute of Immunology, University of Kiel, Kiel, Germany.
  • Walczak H; Centre for Cell Death, Cancer and Inflammation, University College London Cancer Institute, London, United Kingdom.
  • Schütze S; Institute of Immunology, University of Kiel, Kiel, Germany.
  • Janssen O; Institute of Immunology, University of Kiel, Kiel, Germany.
  • Wulczyn FG; Center for Anatomy, Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Wajant H; Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Kalthoff H; Division of Molecular Oncology, Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany.
  • Trauzold A; Division of Molecular Oncology, Institute for Experimental Cancer Research, University of Kiel, Kiel, Germany. Electronic address: atrauzold@email.uni-kiel.de.
Gastroenterology ; 146(1): 278-90, 2014 Jan.
Article en En | MEDLINE | ID: mdl-24120475
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Apoptosis / Carcinoma Ductal Pancreático / MicroARNs / Receptores del Ligando Inductor de Apoptosis Relacionado con TNF Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Gastroenterology Año: 2014 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Apoptosis / Carcinoma Ductal Pancreático / MicroARNs / Receptores del Ligando Inductor de Apoptosis Relacionado con TNF Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Gastroenterology Año: 2014 Tipo del documento: Article País de afiliación: Alemania